Cecilia G. Carvalhaes

781 Pedro De Toledo St
Pedro De Toledo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

A comparative analysis of performance and time-to-result for VITEK REVEAL versus MicroScan during antimicrobial susceptibility testing for gram-negative bacteremia.

A comparative analysis of performance and time-to-result for VITEK REVEAL versus MicroScan during antimicrobial susceptibility testing for gram-negative bacteremia.

Journal: Microbiology spectrum

Published: September 02, 2026

Automated antimicrobial susceptibility testing in gram-negative bacteremia: A comparative study of VITEK® REVEAL™ and BD phoenix™.

Automated antimicrobial susceptibility testing in gram-negative bacteremia: A comparative study of VITEK® REVEAL™ and BD phoenix™.

Journal: Diagnostic microbiology and infectious disease

Published: May 20, 2026

Evaluation of the Impact of Medical Education on Quality and Appropriateness of Blood Culture Management.

Evaluation of the Impact of Medical Education on Quality and Appropriateness of Blood Culture Management.

Journal: The Journal of hospital infection

Published: April 20, 2026

Comparison of the VITEK REVEAL AST and Accelerate Pheno systems for fast antimicrobial susceptibility testing of gram-negative blood cultures at a large academic health system.

Comparison of the VITEK REVEAL AST and Accelerate Pheno systems for fast antimicrobial susceptibility testing of gram-negative blood cultures at a large academic health system.

Journal: Journal of clinical microbiology

Published: December 17, 2025

Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization.

Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization.

Journal: Antimicrobial agents and chemotherapy

Published: September 12, 2024

Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofungin.

Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofungin.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: July 05, 2024

Evaluation of the Activity of Triazoles Against Non-fumigatus Aspergillus and Cryptic Aspergillus Species Causing Invasive Infections Tested in the SENTRY Program.

Evaluation of the Activity of Triazoles Against Non-fumigatus Aspergillus and Cryptic Aspergillus Species Causing Invasive Infections Tested in the SENTRY Program.

Journal: Open forum infectious diseases

Published: March 27, 2024

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis.

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis.

Journal: Antimicrobial agents and chemotherapy

Published: March 25, 2024

In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022).

In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022).

Journal: Antimicrobial agents and chemotherapy

Published: January 11, 2024

Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021).

Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021).

Journal: Journal of clinical microbiology

Published: January 09, 2024

Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020-2022).

Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020-2022).

Journal: International journal of antimicrobial agents

Published: December 15, 2023

Use of isavuconazole antifungal medicine to treat mold infections in Asia and the Western Pacific region: a plain language summary.

Use of isavuconazole antifungal medicine to treat mold infections in Asia and the Western Pacific region: a plain language summary.

Journal: Future microbiology

Published: November 29, 2023

Showing 1-12 of 95

Last Updated: 09/26/2026